Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on sleep in brain health

LIVE: Thursday 2nd May 2024, 18:00-19:30 (CEST)

Quality sleep is essential for health. But what happens to our brains when sleep patterns are disturbed? Join our experts to explore the interplay between sleep disruption and neurological diseases, and the questions that you need to be asking your patients to help you prevent the harmful effects of sleep deprivation.
ADVANCED SEARCH
Log in
Top
Current Pain and Headache Reports
Published in: Current Pain and Headache Reports 9/2014

01-09-2014 | Secondary Headache (K Henry and M Robbins, Section Editors)

Headache and the Pseudotumor Cerebri Syndrome

Authors: Robert M. Mallery, Deborah I. Friedman, Grant T. Liu

Published in: Current Pain and Headache Reports | Issue 9/2014

Login to get access

Abstract

Pseudotumor cerebri syndrome (PTCS) refers to the primary and secondary disorders that cause elevated intracranial pressure without an intracranial mass lesion, ventriculomegaly, or central nervous system infection or malignancy. Headache is the most frequent symptom of PTCS, but there is considerable overlap between the headache features of raised intracranial pressure and the headache features of primary headache disorders. We review headache subtypes that occur in PTCS, non-headache features that help distinguish PTCS from other headache types, changes to the diagnostic criteria for PTCS with and without papilledema, and headache treatment strategies as they apply to PTCS.
Literature
1.
Rangwala LM, Liu GT. Pediatric idiopathic intracranial hypertension. Surv Ophthalmol. 2007;52:597–617.PubMedCrossRef
2.
Balcer LJ, Liu GT, Forman S, et al. Idiopathic intracranial hypertension: relation of age and obesity in children. Neurology. 1999;52:870–2.PubMedCrossRef
3.
Wall M. The headache profile of idiopathic intracranial hypertension. Cephalalgia. 1990;10:331–5.PubMedCrossRef
4.
Giuseffi V, Wall M, Siegel PZ, Rojas PB. Symptoms and disease associations in idiopathic intracranial hypertension (pseudotumor cerebri): a case–control study. Neurology. 1991;41:239–44.PubMedCrossRef
5.
Johnston I, Paterson A. Benign intracranial hypertension. II. CSF pressure and circulation. Brain. 1974;97:301–12.PubMedCrossRef
6.
Wang SJ, Silberstein SD, Patterson S, Young WB. Idiopathic intracranial hypertension without papilledema: a case–control study in a headache center. Neurology. 1998;51:245–9.PubMedCrossRef
7.••
Wall M, Kupersmith MJ, kieburts KD, et al. The idiopathic intracranial hypertension treatment trial: clinical profile at baseline. JAMA neurology 2014;71:693-701. This study describes the baseline clinical characteristics of the IIH Treatment Trial.
8.
Mathew NT, Ravishankar K, Sanin LC. Coexistence of migraine and idiopathic intracranial hypertension without papilledema. Neurology. 1996;46:1226–30.PubMedCrossRef
9.
Bigal ME, Lipton RB. Obesity is a risk factor for transformed migraine but not chronic tension-type headache. Neurology. 2006;67:252–7.PubMedCrossRef
10.
Ravid S, Shahar E, Schiff A, Gordon S. Obesity in children with headaches: association with headache type, frequency, and disability. Headache. 2013;53:954–61.PubMedCrossRef
11.
Peterlin BL, Rosso AL, Williams MA, et al. Episodic migraine and obesity and the influence of age, race, and sex. Neurology. 2013;81:1314–21.PubMedCrossRef
12.•
Chai NC, Scher AI, Moghekar A, Bond DS, Peterlin BL. Obesity and headache: part I—a systematic review of the epidemiology of obesity and headache. Headache. 2014;54:219–34. This literature review discusses the relationship between obesity and primary and secondary headache disorders.PubMedCentralPubMedCrossRef
13.
Biousse V, Ameri A, Bousser MG. Isolated intracranial hypertension as the only sign of cerebral venous thrombosis. Neurology. 1999;53:1537–42.PubMedCrossRef
14.
Lepore FE. Unilateral and highly asymmetric papilledema in pseudotumor cerebri. Neurology. 1992;42:676–8.PubMedCrossRef
15.
Huna-Baron R, Landau K, Rosenberg M, Warren FA, Kupersmith MJ. Unilateral swollen disc due to increased intracranial pressure. Neurology. 2001;56:1588–90.PubMedCrossRef
16.
Friedman DI, Forman S, Levi L, Lavin PJ, Donahue S. Unusual ocular motility disturbances with increased intracranial pressure. Neurology. 1998;50:1893–6.PubMedCrossRef
17.
Bortoluzzi M, Di Lauro L, Marini G. Benign intracranial hypertension with spinal and radicular pain. Case report. J Neurosurg. 1982;57:833–6.PubMedCrossRef
18.
Comabella M, Montalban J, Lozano M, Codina A. Lhermitte’s sign in pseudotumour cerebri. J Neurol. 1995;242:610–1.PubMedCrossRef
19.
Fay T. A new test for the diagnosis of certain headaches: the cephalogram. Dis Nerv Syst. 1940;1:312–5.
20.••
Friedman DI, Liu GT, Digre KB. Revised diagnostic criteria for the pseudotumor cerebri syndrome in adults and children. Neurology. 2013;81:1159–65. This article introduces a revision to the terminology and diagnostic criteria for PTCS.PubMedCrossRef
21.
The International Classification of Headache Disorders, 3rd edition (beta version). Cephalalgia. 2013;33:629–808.
22.•
McGeeney BE, Friedman DI. Pseudotumor cerebri pathophysiology. Headache. 2014;54:445–58. This review article discusses the pathophysiology of primary PTCS, including a discussion of hormonal effects on CSF outflow resistance.PubMedCrossRef
23.
Gjerris F, Soelberg Sorensen P, Vorstrup S, Paulson OB. Intracranial pressure, conductance to cerebrospinal fluid outflow, and cerebral blood flow in patients with benign intracranial hypertension (pseudotumor cerebri). Ann Neurol. 1985;17:158–62.PubMedCrossRef
24.
Janny P, Chazal J, Colnet G, Irthum B, Georget AM. Benign intracranial hypertension and disorders of CSF absorption. Surg Neurol. 1981;15:168–74.PubMedCrossRef
25.
Mann JD, Johnson RN, Butler AB, Bass NH. Impairment of cerebrospinal fluid circulatory dynamics in pseudotumor cerebri and response to steroid treatment. Neurology. 1979;29:550.CrossRef
26.
Wall M. Idiopathic intracranial hypertension and the idiopathic intracranial hypertension treatment trial. J Neuroophthalmol. 2013;33:1–3.PubMedCrossRef
27.
McGonigal A, Bone I, Teasdale E. Resolution of transverse sinus stenosis in idiopathic intracranial hypertension after LP shunt. Neurology. 2004;62:514–5.PubMedCrossRef
28.
Bono F, Giliberto C, Mastrandrea C, et al. Transverse sinus stenoses persist after normalization of the CSF pressure in IIH. Neurology. 2005;65:1090–3.PubMedCrossRef
29.
Ahmed RM, Zmudzki F, Parker GD, Owler BK, Halmagyi GM. Transverse sinus stenting for pseudotumor cerebri: a cost comparison with CSF shunting. AJNR Am J Neuroradiol. 2013.
30.
Stevens SA, Stimpson J, Lakin WD, Thakore NJ, Penar PL. A model for idiopathic intracranial hypertension and associated pathological ICP wave-forms. IEEE Trans Biomed Eng. 2008;55:388–98.PubMedCrossRef
31.
Bateman GA, Stevens SA, Stimpson J. A mathematical model of idiopathic intracranial hypertension incorporating increased arterial inflow and variable venous outflow collapsibility. J Neurosurg. 2009;110:446–56.PubMedCrossRef
32.
Daniels AB, Liu GT, Volpe NJ, et al. Profiles of obesity, weight gain, and quality of life in idiopathic intracranial hypertension (pseudotumor cerebri). Am J Ophthalmol. 2007;143:635–41.PubMedCrossRef
33.
Johnson LN, Krohel GB, Madsen RW, March Jr GA. The role of weight loss and acetazolamide in the treatment of idiopathic intracranial hypertension (pseudotumor cerebri). Ophthalmology. 1998;105:2313–7.PubMedCrossRef
34.•
Ko MW, Chang SC, Ridha MA, et al. Weight gain and recurrence in idiopathic intracranial hypertension: a case–control study. Neurology. 2011;76:1564–7. This case–control study demonstrates that weight gain is associated with recurrence of PTCS.PubMedCrossRef
35.
Sinclair AJ, Burdon MA, Nightingale PG, et al. Low energy diet and intracranial pressure in women with idiopathic intracranial hypertension: prospective cohort study. BMJ. 2010;341:c2701.PubMedCentralPubMedCrossRef
36.
Sugerman HJ, Felton 3rd WL, Salvant Jr JB, Sismanis A, Kellum JM. Effects of surgically induced weight loss on idiopathic intracranial hypertension in morbid obesity. Neurology. 1995;45:1655–9.PubMedCrossRef
37.
Rubin RC, Henderson ES, Ommaya AK, Walker MD, Rall DP. The production of cerebrospinal fluid in man and its modification by acetazolamide. J Neurosurg. 1966;25:430–6.PubMedCrossRef
38.
Ball AK, Howman A, Wheatley K, et al. A randomised controlled trial of treatment for idiopathic intracranial hypertension. J Neurol. 2011;258:874–81.PubMedCrossRef
39.••
Wall M, McDermott MP, Kieburtz KD, et al. Effect of acetazolamide on visual function in patients with idiopathic intracranial hypertension and mild visual loss: the idiopathic intracranial hypertension treatment trial. JAMA J Am Med Assoc. 2014;311:1641–1651. This is a randomized-controlled trial comparing visual field function in patients with IIH and mild vision loss treated with acetazolamide and weight-reduction diet versus diet alone.
40.
Schoeman JF. Childhood pseudotumor cerebri: clinical and intracranial pressure response to acetazolamide and furosemide treatment in a case series. J Child Neurol. 1994;9:130–4.PubMedCrossRef
41.
McCarthy KD, Reed DJ. The effect of acetazolamide and furosemide on cerebrospinal fluid production and choroid plexus carbonic anhydrase activity. J Pharmacol Exp Ther. 1974;189:194–201.PubMed
42.
Celebisoy N, Gokcay F, Sirin H, Akyurekli O. Treatment of idiopathic intracranial hypertension: topiramate vs acetazolamide, an open-label study. Acta Neurol Scand. 2007;116:322–7.PubMedCrossRef
43.
Banta JT, Hoffman K, Budenz DL, Ceballos E, Greenfield DS. Presumed topiramate-induced bilateral acute angle-closure glaucoma. Am J Ophthalmol. 2001;132:112–4.PubMedCrossRef
44.
Craig JE, Ong TJ, Louis DL, Wells JM. Mechanism of topiramate-induced acute-onset myopia and angle closure glaucoma. Am J Ophthalmol. 2004;137:193–5.PubMedCrossRef
45.
Bynke G, Zemack G, Bynke H, Romner B. Ventriculoperitoneal shunting for idiopathic intracranial hypertension. Neurology. 2004;63:1314–6.PubMedCrossRef
46.
Rosenberg ML, Corbett JJ, Smith C, et al. Cerebrospinal fluid diversion procedures in pseudotumor cerebri. Neurology. 1993;43:1071–2.PubMedCrossRef
47.
Burgett RA, Purvin VA, Kawasaki A. Lumboperitoneal shunting for pseudotumor cerebri. Neurology. 1997;49:734–9.PubMedCrossRef
48.
Eggenberger ER, Miller NR, Vitale S. Lumboperitoneal shunt for the treatment of pseudotumor cerebri. Neurology. 1996;46:1524–30.PubMedCrossRef
49.
McGirt MJ, Woodworth G, Thomas G, Miller N, Williams M, Rigamonti D. Cerebrospinal fluid shunt placement for pseudotumor cerebri-associated intractable headache: predictors of treatment response and an analysis of long-term outcomes. J Neurosurg. 2004;101:627–32.PubMedCrossRef
50.
Corbett JJ, Nerad JA, Tse DT, Anderson RL. Results of optic nerve sheath fenestration for pseudotumor cerebri. The lateral orbitotomy approach. Arch Ophthalmol. 1988;106:1391–7.PubMedCrossRef
51.
Spoor TC, McHenry JG. Long-term effectiveness of optic nerve sheath decompression for pseudotumor cerebri. Arch Ophthalmol. 1993;111:632–5.PubMedCrossRef
52.
Goh KY, Schatz NJ, Glaser JS. Optic nerve sheath fenestration for pseudotumor cerebri. J Neuroophthalmol. 1997;17:86–91.PubMedCrossRef
53.
Ahmed R, Friedman DI, Halmagyi GM. Stenting of the transverse sinuses in idiopathic intracranial hypertension. J Neuroophthalmol. 2011;31:374–80.PubMedCrossRef
54.
Higgins JN, Cousins C, Owler BK, Sarkies N, Pickard JD. Idiopathic intracranial hypertension: 12 cases treated by venous sinus stenting. J Neurol Neurosurg Psychiatry. 2003;74:1662–6.PubMedCentralPubMedCrossRef
55.
Radvany MG, Solomon D, Nijjar S, et al. Visual and neurological outcomes following endovascular stenting for pseudotumor cerebri associated with transverse sinus stenosis. J Neuroophthalmol. 2013;33:117–22.PubMedCrossRef
Metadata
Title
Headache and the Pseudotumor Cerebri Syndrome
Authors
Robert M. Mallery
Deborah I. Friedman
Grant T. Liu
Publication date
01-09-2014
Publisher
Springer US
Published in
Current Pain and Headache Reports / Issue 9/2014
Print ISSN: 1531-3433
Electronic ISSN: 1534-3081
DOI
https://doi.org/10.1007/s11916-014-0446-z

Other articles of this Issue 9/2014

Current Pain and Headache Reports 9/2014 Go to the issue

Secondary Headache (K Henry and M Robbins, Section Editors)

Reversible Cerebral Vasoconstriction Syndrome: a Comprehensive Update

Secondary Headache (K Henry and M Robbins, Section Editors)

Headache in Behçet’s Syndrome: Review of Literature and NYU Behçet’s Syndrome Center Experience

Anesthetic Techniques in Pain Management (D Wang, Section Editor)

Treatment of Cervicogenic Headache with Cervical Epidural Steroid Injection

Psychiatric Management of Pain (M Clark, Section Editor)

Negotiating the Maze: Risk Factors for Suicidal Behavior in Chronic Pain Patients

Secondary Headache (K Henry and M Robbins, Section Editors)

Headache and Acute Stroke

Myofascial Pain (R Gerwin, Section Editor)

Myofascial Low Back Pain Treatment